| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |